(Q44503086)

https://doi.org/10.1002/ijc.34482

3 December 2017

1 reference

29 December 2023

https://retractionwatch.com/2023/01/11/japanese-university-asks-surgeon-to-retract-eight-fraudulent-papers/

title

Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil (English)

1 reference

oral squamous cell carcinoma

3 December 2017

main subject

1 reference

1 reference

Masayasu Iwase

1

1 reference

3 December 2017

Hitoshi Watanabe

2

1 reference

3 December 2017

Gen Kondo

3

1 reference

3 December 2017

Masaru Ohashi

4

1 reference

3 December 2017

Masao Nagumo

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

International Journal of Cancer

3 December 2017

published in

1 reference

3 December 2017

volume

106

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

619-625

1 reference

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells

3 December 2017

cites work

1 reference

Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells

21 January 2018

1 reference

Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.

21 January 2018

1 reference

Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures

21 January 2018

1 reference

FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Apoptosis by death factor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2-activated cytotoxic lymphocytes combined with radiation and anticancer drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Caspases: enemies within

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Elevated production of salivary nitric oxide in oral mucosal diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

CD95(APO-1/Fas)-mediated apoptosis: live and let die

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Apoptosis in cancer therapy: crossing the threshold

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Changes in susceptibility to Fas-mediated apoptosis during differentiation of HL-60 cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Inhibition of fas death signals by FLIPs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

5-Fluorouracil suppression of NF-KappaB is mediated by the inhibition of IKappab kinase activity in human salivary gland cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Apoptosis induced by anticancer drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Fas antigen expression and outcome of oral squamous cell carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Selective expression of FLIP in malignant melanocytic skin lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

NF-kappaB signals induce the expression of c-FLIP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Death receptors: signaling and modulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Increased expression of cFLIP(L) in colonic adenocarcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Inhibition of death receptor signals by cellular FLIP

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/IJC.11239

Identifiers

DOI

10.1002/IJC.11239

1 reference

3 December 2017

1 reference